Back to Markets

ABT vs LLY

A side-by-side look at ABT and LLY, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

ABT vs LLY: how they differ

Abbott Laboratories (ABT) and Eli Lilly and Company (LLY) are both in the Healthcare sector: ABT is classified in Medical - Devices, LLY in Drug Manufacturers - General. Both trade on NYSE.

ABT trades about 10.5 million shares a day on average, against 2.6 million for LLY. ABT has the higher beta (0.58 against 0.45 for LLY), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABT paid $2.52 per share in dividends and LLY paid $6.69 per share.

Figures as of October 25, 2026.

More comparisons

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.